In vivo human major histocompatibility complex (MHC) α-chain gene transfer into pig hearts by intracoronary delivery  by Popov, Alexander et al.
JACC Febras~ 1996 ABSTRACTS- Po~cr 207A 
~ l n  Vivo Human Major Hlstocompatibility Complex 
(MHC) ,-,-Chain Gene Transfer I , to  Pig Hearts by 
Inlmcoronery Bel ivery 
Alexander Popov, Ivan Alekslc, Melna Ren, Eliot Con:lay, Peter Barath. 
Cedars-Sinei Medical Center, Los Angeles, CA 
We hypothesized that transfeution of the rectpient's MHC genes intc the 
donor heart results in the expression of the MHC gene product on the dot,or 
organ cell surface, which might facilitate the acceptance of both allo- and 
xenegrefis, Methods: To demonstrate the feasibility and determine the opti- 
mal characteristics of the human MHC gene transfer into an animal organ in 
vivo, the isolated and purified gene was incubated in reties 1:1 to 1:10 with 
lipofentin for 10 min. Then we supersalentivaly cannulated the apical segment 
of the LAD of normal pigs with a non-occlusive PE catheter and delivered 
the gune/lipofectin cumplex (500/~g DNA/anima]) over 30 rain. The animals 
were sacrificed in 4, 24, 48 and 72 hours (4 animals/group). We detected 
the gune product by Immunohlstochemical staining using monodonal anti- 
body to human cz chain. Negative controls: lipofectin delivery alone, deletion 
of pdmaty antibody. Positive control: human tonsils. Reeu~: In the carder 
positive ames (oil red O detection), the endothel!al cells of the capillaries, 
arterioles and small artefles revealed a strong confluent immunohislochemi- 
sal a chain posltlvlty. At 48 h moderately, chain positive mononudear cells 
appeared in the areas where the endothelial sells were also = chaJn positive. 
The myocardial cells remained negative. The gone expression reached its 
maximum at 24 h but was still present at 72 h. The optimal DNA/lipofectin 
ratio was 1:4. Conclusion: 1. Intracurouary derwery of human MHC gene 
results in the expression of this gene in the endothelial cells of the pig hearts. 
2. The efficiency of the tmnstoction depends on the DNA/tipofectin ratio and 
the timing. 
~ ' ~  Prevention of  Graft Atherosclerosis by DiItlazem in 
Heart Transplantation: A Pure Veaodilatory Effect? 
Barbara K. Julius, Giusr.~z Vassalli, Marko Turlna, Wolfgsng Kiowskl, Otto 
M. Hess. C, ard/oiogy and Cardiovascular Surge~ University Hospital, 
Zurich, Sw#zerland 
Background: Diltlazem has been shown to prevent he ocourrenoe of graft 
atharescteresls after heart transplantation (HTX). Patients and Methods: 23 
patients (pis) were studied 3 and 12 monks after HTX. At baseline exam- 
Ination pts were randomized to receive either Diltiazem (D) or no calcium 
antagonist (C). Coronary cross-sectional area (CSA) was determined by bk 
plane quantitative coronary anglogrupby at rest (R), dudeg supine bicycle 
exercise (Ex), after 10 mg Intracumnary papavedn (PAP) as well as 1.6 mg 
subllngual nifregtycedn (NTG). Results:Them was a significant reduction in 
CSA at 12 months follow-up in C but not in Diltiazem-trsated pis. However, 
PAP- (18 vs 40%) as well as NTG-induced vasedilatton (31 vs 49%) was 
reduced at follow-up examination in Diltiasem-treated pis when compared to 
C. 
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Conclusions:The decrease in coronary artery dimensions is prevented by 
Dlltlazem in H'rx 10ts during short-term fogow-up. However, this effect is due 
to coronary vesodilation rather than to prevention of graft atherosdemsis. 
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~ Reaponea to Treatment at Neurelly Directed 
Mediated Hypotenslon Among Patients With 
Chronic Fatigue Syndrome: Can It Be Predicted? 
lssam Bou-Holaigah, Peter Rowe, Jean S. Kan, Hugh C, alkins. The Johns 
Hopkins Medical Institutions, Battimom, MD 
Recent studies have reported a dose association between chronic fatigue 
syndrome (CFS) and neurally mediated hypetensiort (NMH) with treatment 
directed at NMH resulting in near complete resolution of symptoms in a 
subset of patients with chronic fatigue syndrome (CFS). The purpose of this 
study was to compare the clinical characteristics and response to upright 
tilt (tilt) of those CFS patients with and without a favorable response to 
treatmenL Nineteen patients with CFS and a positive response to tilt were 
treated (16 F ,3 M, 32 =I: 13 yre). The mean duration of follow-up was 24 
:E 5 weeks. Nine patients experienced near total resolution of symptoms. 
Clinical characteristics evaluated included age, sex, duration and severity of 
symptoms, and stage of positive response to till Severity of symptoms was 
based on a 5 paint soale (5 = most severe). 
RasuitS: Patients with a favorable response to treatment had a shorter 
duretion of symptoms (40 :b 28 vs 87 =t: 52 m, p = 0.03), and less severe 
symptoms (3.8 :E 0.8 vs 4.8 ~ 0.4, p < 0.01 ). There was no difference in age 
(33 ± 13 vs 31 4- 14, p = 0.8), number of prior failed rx (2.2 ± 1.9 vs 4.0 :E 
3.6, p = 0.2), male sex (2/9 vs 1/10, p = 0.14) or the proportion of patients 
who had a posilive responsa during phase I of tilt (5/9 vs 9/10, p = 0.14). 
Conc/b,~ions: Patients with chronic fatigue syndrome who demonstrate a
favorable response to treatment directed at NMH are characterized by less 
severe symptoms of shorter duration. 
~ Diagnostlc Utility of  Mechanical, Phm'macological 
and Orthostatle Stimulation of  the CaroUd Sinus in 
Patients With Unexplained Syncope 
Carlos A. ModlTo, Mark A. Wood, David M. Gilligan, Dwaln L Eckberg, 
Kenneth A. Ellenbogen. McGuire VA Medical Center, Med'~cal College of 
Virginia, Richmond, VA 
Carotid sinus hypersensitivity (CSH) is a frequently unrecognized cause of 
unexplained ~ usu~ly diagnosed by ellidting significant bradycar- 
dia/hypotension dudng carotid sinus massage (CSM) in the supine position. 
The diagnostic utility of mechanical, pham~cologicat and orthostatic stimu- 
lation of the carotid sinus was assessed in 37 consecutive patients (mean 
age 33 ~ 2.3 yr) with unexplained syncope. ECG and blood pressure were 
continuoesly recorded; a 100 ~0 boles of nitropmeside [N) was administered 
and followed after 60 seconds by 150 jug of phenylephfine (P). After 10 min- 
utes of recovery CSM was performed in the supine position, and 2 minutes 
after assuming a 60 Q upright position. A 60 Q low-dose isoproterenol hP.ad-gp 
tilt (HUT) was performed in all patients. 
HRb ~HRN &HRP AHR(P nHR60 o ~SP0 a ASP6(P n 
CSH[-| 72 18 21 6 8 8 10 16 
CSH[÷] 70 14 13 15 25" 17 58" 21 
HRb: baseline heart rate, &HR: heart rate change, beats/rain, &SP: systor¢ blood pres- 
sure change, mnVHg. *p < 0.05 batwsen groups. 
CSH was diagnosed in only 3 (8%) patients in the supine position, and in 
18 (48%) in the uptight position increasing the diagnostic yield by 40°/,. HUT 
was positive in 4 (19%) pabents with CSH. 
Conc/usions: Assessment of CSM during orthostat~ stress identifies an 
add'~onat 40% of patients with CSH othen~se unrecognized by CSM per- 
formed in the supine position. Pharmacologic assessment does not add any 
additional information.. 
~5"~ Influence on Autonomic Balance During Head-Up 
Tilt o f  Endoscopic Trensthoracic Sympathicotomy 
Satom Sake ,  Takee Tedoriya, Manal0u F~moto, Yukio Nakamura. 
Takashi Ueyama. Kanazawa Nalional Hosp/tal, Kanazawa, Japan 
Endoscopic tmnsthorasio sympathicsfomy (ETS) is a minimal invasive pro- 
eedure of thoracio ~ bl~ck. ETS is done under genereJ anesthesia, 
m¢l after carbon a]oxide insoffiation of the pteural cavity, the upper thoracic 
sy~c chain is electroeeegulated. ETS has been used su~ul ly  in 
the treatment of pfimaw palmar hyperhidoresls. To invasUgate the influence 
of ET~ on cardiac autonomic funotion, we analyzed heart rate vadabglty dur- 
leg Ilead-up tift teet before and after ETS in 12 pa~ents with pfimaPJ palmar 
hyperhidom6is. The InolinatJon of the table was varied at the following angle: 
0~, 30g, 6Q~z, 90g, aed maintained for 10 minutos at eash angle. Frem the con- 
tinuous ECG, s y ~  valance was determined with power spectral 
analysis of heart rate variability using a maximal entropy method. 
RR (reset) LF (m~.) HF (ms2) LF/HF 
0o (before) 944=I=94 642 -~- 235 1072±1260 1.0 :t:0.6 
O~ (after) 9174-156 437:1:290 623-*-487 1.1 ±0.9 
30~ (before) 821±119 504 :E 221 ° 286 ±203 3.t =E2.9" 
30o (altor) 840:b 169 277=1=245" 272:1:207 1.3± 1.0 ° 
60~ (bafom) 735:b91 606 ± 404" 219 -~- 281 6.7±8.1 ° 
60o (6fter) 765:1:128 241-1-173" 192-4-170 3.6±2.4 ° 
90t (be[ore) 671±95" 568:E440" 82 ::t: 50 9.4 ~9.1" 
90g (after) 7364-136"  259-1-197" ~2-;-71 5.3 :E 4.7 = 
*p < 0.05, LF: low frequency, HF: high frequency 
These data st&~;.c--st that ETS suppress the excitation of the sympathetic 
